Powder: -20°C for 3 years | In solvent: -80°C for 1 year
M109S is a novel small molecule that shields cells from mitochondria-dependent apoptosis, demonstrating effectiveness both in vitro and in vivo. It shows promise as a research tool for probing cell death mechanisms and could lead to the development of therapeutics that target the mitochondria-dependent cell death pathway. M109S possesses oral bioactivity and excellent brain permeability [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,670.00 | |
50 mg | 8-10 weeks | $ 2,180.00 | |
100 mg | 8-10 weeks | $ 2,800.00 |
Description | M109S is a novel small molecule that shields cells from mitochondria-dependent apoptosis, demonstrating effectiveness both in vitro and in vivo. It shows promise as a research tool for probing cell death mechanisms and could lead to the development of therapeutics that target the mitochondria-dependent cell death pathway. M109S possesses oral bioactivity and excellent brain permeability [1]. |
Targets&IC50 | Caspase-3:23.4 nM (EC50) |
In vitro | M109S, at concentrations ranging from 0.1 to 10,000 nM over 24 to 48 hours, inhibits Bax- and Bak-induced apoptosis [1]. Additionally, M109S at 0 to 10 μM for 4 hours suppresses Staurosporine-induced apoptosis in MEF cells. It also prevents apoptosis in Neuro2a cells initiated by Etoposide when applied at 0 to 10μM for 24 hours [1]. At a concentration of 500 nM for 24 hours, M109S inhibits Obatoclax-induced apoptosis in ARPE19 cells [1]. Furthermore, at 500 nM for 48 hours, M109S inhibits Bax conformational change (N-terminus exposure) and mitochondrial translocation [1]. At 1.0 μM for 4 hours, M109S reduces mitochondrial oxygen consumption and reactive oxygen species, while M109S at 0.1 to 1 nM for 4 hours increases glycolysis [1]. |
In vivo | M109S, administered at a dose of 10 mg/kg through oral gavage three times within 48 hours, protects the retina from photoreceptor cell death induced by intense light exposure [1]. As an orally bioactive cell death inhibitor that penetrates the blood-brain/retinal barrier, M109S can be delivered via intraperitoneal injection at 1 mg/kg, intravenous injection at 5 mg/kg, or oral gavage at 10 mg/kg in a single dose [1]. |
Molecular Weight | 375.42 |
Formula | C21H21N5O2 |
CAS No. | 2578300-07-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
M190S 2578300-07-7 Apoptosis Proteases/Proteasome Caspase inhibitor inhibit